CONMED Corporation

Healthcare · Medical - Devices

Overall research band Mixed

Quality Mixed

Valuation Exceptional

Balance sheet Very weak

Market confirmation Strong

One-minute company read

What this report can tell you now

What the company does

CONMED Corporation is a medical technology company that develops, manufactures, and distributes surgical instruments and related devices for various surgical procedures worldwide. Its main products include specialized orthopedic surgical items such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors, marketed under brands like Hall, CONMED Linvatec, Concept, and Shutt. The company also offers general surgical equipment for insufflation, smoke evacuation, electrosurgery, and endomechanical uses, as well as endoscopic technology for gastroenterological and biliary procedures. Additionally, CONMED provides cardiac monitoring solutions, including ECG and EEG electrodes and defibrillation pads. Its customers are primarily hospitals and surgical centers, and products are distributed both directly and through specialized medical distributors. Revenue is generated from the sale of these medical devices and equipment.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC5.1%Model input; read with the evidence status and period context.

Operating margin10.3%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years8.0%Model input; read with the evidence status and period context.

FCF margin11.0%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.